Olanzapine associated weight gain, Hyperglycemia and Neuroleptic Malignant Syndrome: case report

被引：9

作者：

Malyuk, R

Gibson, B

Procyshyn, RM

Kang, N

机构：

[1] Riverview Hosp, Div Med Serv, Port Coquitlam, BC V3C 4J2, Canada

[2] Riverview Hosp, Dept Pharm, Port Coquitlam, BC V3C 4J2, Canada

[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada

来源：

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY | 2002年 / 17卷 / 04期

关键词：

olanzapine; weight gain; Hyperglycemia; Neuroleptic Malignant Syndrome;

D O I：

10.1002/gps.596

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

We describe here a case of olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome in a 64 year-old woman with a significant medical history. Eighteen weeks after initiating olanzapine, Mrs X lost glycemic control, exhibited signs and symptoms consistent with neuroleptic malignant syndrome and gained 8.9 kg. We suggest that utilization of olanzapine in the less medically stable geriatric patient be implemented with vigilant monitoring for such complications mentioned above. Copyright (C) 2002 John Wiley Sons, Ltd.

引用

页码：326 / 328

页数：3

共 19 条

[1]

BEASLEY CM, 1997, J CLIN PSYCHIAT MONO, V15, P19

[2] Olanzapine induced neuroleptic malignant syndrome [J].